Results 111 to 120 of about 23,377 (228)

The Effects of Prednisone and Prednisone Plus Ultralow-dose Aspirin on Coagulation Parameters in Healthy Dogs

, 2012
Objectives: To determine the effects of prednisone and prednisone plus ultralow-dose aspirin on coagulation in healthy dogs, and to determine intra-individual variation in thromboelastography (TEG).
O'Kell, Allison Louise
core  

Chemical derivatization of prednisone / Marliana Mohd Jajuli [PDF]

, 2013
Prednisone gives many benefits to human in medical field because of its anti­ inflammatory effect. These favorable benefits lead to the development of many synthetic compounds with much greater anti-inflammatory activity than the natural hormones ...
Mohd Jajuli, Marliana
core  

A 12-WEEK COMBINATION OF CLARITHROMYCIN AND PREDNISONE COMPARED TO A 24-WEEK PREDNISONE ALONE TREATMENT IN CRYPTOGENIC AND RADIATION-INDUCED ORGANIZING PNEUMONIA

, 2018
International audienceBackground Some data suggest that anti-inflammatory macrolides may be effective to treat organizing pneumonia (OP) and prevent relapses, but no formal comparison with prednisone alone is available.
Marchand-Adam, Sylvain, Petitpierre, Nicolas, Court-Fortune, Isabelle, Hirschi, Sandrine, Cottin, Vincent, Israel-Biet, Dominique, Cordier, Jean-Francois, Lazor, Romain, Jouneau, Stéphane, Rigaud, Dominique, Molard, Anita   +10 more
core   +1 more source

Shared and Distinguishing Features of Late‐Onset Rheumatic Diseases Fulfilling Polymyalgia Rheumatica Classification Criteria

Arthritis &Rheumatology, Accepted Article.
‐
Kerem Abacar, Ala Altaie, Andrew Barr, Sarah L. Mackie, Kulveer Mankia, Dennis McGonagle   +5 more
wiley   +1 more source

Exploring the potential of cluster analysis in identifying disease phenotypes in CPPD: Moving from intuition to insight

Arthritis &Rheumatology, Accepted Article.
Background Calcium pyrophosphate deposition (CPPD) disease is a heterogeneous condition and is frequently misdiagnosed due to the different clinical presentations and variable disease progression. Aim of this study is to identify clinical phenotypes of CPPD disease by integrating real‐world data from two datasets. Methods Data from the COLCHICORT trial
Greta Pellegrino, Laurène Norberciak, Silvia Sirotti, Abhishek Abhishek, Mariano Andrès, Edoardo Cipolletta, Julien Damart, Renaud Desbarbieux, Pilar Diez, Vincent Ducoulombier, Hang‐Korng Ea, Emilio Filippucci, Charlotte Jauffret, Augustin Latourte, Jean‐Guillaume Letarouilly, Sébastien Ottaviani, Laura Pezzoni, Pascal Richette, Pierre Robinet, Georgios Filippou, Tristan Pascart   +20 more
wiley   +1 more source

Rapid discontinuation of prednisone in higher-risk kidney transplant recipients

, 2004
Prednisone-minimization protocols have been successful in low-risk recipients. We report on the use of a protocol incorporating rapid discontinuation of prednisone in a cohort of kidney transplant recipients (n = 79) at increased immunologic risk.
Raja Kandaswamy, Asolati, Massimo, Sutherland, David E.R., Massimo Asolati, Gruessner, Rainer W.G., Najarian, John S., Khwaja, Khalid, Khalid Khwaja, James V. Harmon, David E. R. Sutherland, Dunn, David L., Kandaswamy, Raja, David L. Dunn, John S. Najarian, Gillingham, Kristen J., Payne, William D., Kristen J. Gillingham, Arthur J. Matas, Matas, Arthur J., Rainer W. G. Gruessner, Melancon, J. Keith, Humar, Abhinav, William D. Payne, Harmon, James V., Abhinav Humar, J Keith Melancon, Dunn, Ty B., Ty B. Dunn   +27 more
core   +1 more source

Current evidence and insights on single vs. double dose of basiliximab in adult solid organ transplant recipients: A systematic review

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this systematic review was to assess all available clinical data regarding the use of a single dose of basiliximab in solid organ transplantation compared to the standard double dosage, with particular interest in efficacy, safety and cost‐savings.
Alessio Provenzani, Braidon A. Lape, Anneliese M. Harp, Victoria Weisbrod, Lavinia Piazza   +4 more
wiley   +1 more source

Glucocorticoid exposure and initiation of SSRIs among patients with rheumatoid arthritis: A nested case–control study in UK primary care

British Journal of Clinical Pharmacology, EarlyView.
Aim The immune system might affect the development of anxiety disorders, though mechanisms remain unclear. This nested case–control study investigates whether use of glucocorticoids, potent immunosuppressants, is associated with SSRI initiation (a proxy for pharmacologically treated mental disorders, predominantly depression and/or anxiety).
Elise J. Heesbeen, Patrick C. Souverein, Eibert R. Heerdink, Elisabeth Y. Bijlsma, Lucianne Groenink   +4 more
wiley   +1 more source

Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial

, 2007
To compare the efficacy of prednisone plus infliximab with that of prednisone plus placebo in patients with newly diagnosed polymyalgia rheumatica. DESIGN: Randomized, placebo-controlled trial. SETTING: 7 rheumatology clinics in Italy. PATIENTS: 51
Manganelli, Paolo, Trotta, Aldo, Hunder, Gene G., Manzini, Carlo, Paolazzi, Giuseppe, Klersy, Catherine, Cantini, Fabrizio, Catanoso, Maria Grazia, Gerli, Roberto, SALVARANI, CARLO, Cimmino, Marco, Boiardi, Luigi, Macchioni, Pierluigi   +12 more
core   +1 more source

Model‐informed optimal dose selection of golcadomide in combination with R‐CHOP in patients with previously untreated aggressive B‐cell lymphoma

British Journal of Clinical Pharmacology, EarlyView.
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng, Zhiling Yu, Mark Kaplan, Argyrios Gkasiamis, Akshay Sudhindra, Li Zhu, Manisha Lamba, Fan Wu   +7 more
wiley   +1 more source